Comment le bénéfice par action récent de 02216.HK se compare-t-il aux attentes ?
Comment les revenus de Broncus Holding Corporation 02216.HK se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Broncus Holding Corporation ?
Quel est le score de qualité des bénéfices pour Broncus Holding Corporation ?
Quand Broncus Holding Corporation publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Broncus Holding Corporation ?
Broncus Holding Corporation a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$2.3
Prix d'ouverture
$2.32
Plage de la journée
$2.27 - $2.32
Plage de 52 semaines
$0.58 - $3.72
Volume
473.0K
Volume moyen
875.5K
BPA (TTM)
-0.23
Rendement en dividend
--
Capitalisation boursière
$1.2B
Qu’est-ce que BRONCUS-B ?
Broncus Holding Corp. engages in the research and development, and manufacturing, and commercialization of medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 193 full-time employees. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.